United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $513,295,909.51
Most recent insider trade:
  • Sept. 22, 2022
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 24, 2017CEO1,253$124.07Sell$155,459.71
Nov. 16, 2017CEO7,061$121.12Sell$855,228.32
Nov. 9, 2017CEO1,260$121.46Sell$153,039.60
Nov. 6, 2017Director580$122.00Sell$70,760.00
Nov. 2, 2017CEO1,269$118.04Sell$149,792.76
Oct. 26, 2017CEO1,263$120.38Sell$152,039.94
Oct. 19, 2017CEO1,265$119.38Sell$151,015.70
Oct. 12, 2017CEO1,263$120.20Sell$151,812.60
Oct. 5, 2017CEO1,256$122.98Sell$154,462.88
Oct. 5, 2017Director580$122.00Sell$70,760.00
Sept. 28, 2017CEO1,265$119.70Sell$151,420.50
Sept. 21, 2017CEO1,274$116.07Sell$147,873.18
Sept. 14, 2017CEO1,258$122.08Sell$153,576.64
Sept. 7, 2017CEO1,232$133.32Sell$164,250.24
Sept. 7, 2017Director580$134.48Sell$77,998.40
Aug. 31, 2017CEO1,235$130.49Sell$161,155.15
Aug. 24, 2017CEO1,238$130.65Sell$161,744.70
Aug. 17, 2017CEO1,235$131.95Sell$162,958.25
Aug. 10, 2017CEO2,176$127.11Sell$276,591.36
Aug. 3, 2017CEO1,248$126.41Sell$157,759.68
July 27, 2017CEO1,247$126.40Sell$157,620.80
July 20, 2017CEO1,236$131.62Sell$162,682.32
July 13, 2017CEO1,238$130.44Sell$161,484.72
July 6, 2017Director590$132.61Sell$78,239.90
July 6, 2017CEO1,234$132.29Sell$163,245.86
July 5, 2017Director3,490$131.12Sell$457,608.80
June 29, 2017CEO1,237$130.92Sell$161,948.04
June 23, 2017Director3,490$131.71Sell$459,667.90
June 22, 2017CEO1,234$132.32Sell$163,282.88
June 15, 2017CEO1,238$130.20Sell$161,187.60
June 8, 2017CEO1,240$129.60Sell$160,704.00
June 1, 2017CEO1,251$125.02Sell$156,400.02
May 25, 2017CEO1,265$119.40Sell$151,041.00
May 18, 2017CEO1,261$120.72Sell$152,227.92
May 11, 2017CEO1,259$122.00Sell$153,598.00
May 4, 2017CEO1,258$122.24Sell$153,777.92
April 27, 2017CEO1,262$120.78Sell$152,424.36
April 20, 2017CEO1,260$121.14Sell$152,636.40
April 13, 2017CEO1,258$122.12Sell$153,626.96
April 6, 2017CEO1,257$122.39Sell$153,844.23
March 30, 2017CEO1,230$134.56Sell$165,508.80
March 23, 2017CEO1,219$139.33Sell$169,843.27
March 22, 2017Director2,000$139.37Sell$278,740.00
March 16, 2017CEO1,218$140.16Sell$170,714.88
March 9, 2017CEO1,206$146.72Sell$176,944.32
March 2, 2017CEO1,203$148.49Sell$178,633.47
Feb. 23, 2017CEO1,208$145.16Sell$175,353.28
Feb. 16, 2017CEO1,173$167.92Sell$196,970.16
Jan. 12, 2017Director5,000$141.99Sell$709,950.00
Jan. 12, 2017CEO1,214$142.37Sell$172,837.18
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Roger Jeffs, Paul A Mahon, Martine A. Rothblatt, Martine Rothblatt, John Maxim Ferrari, Christopher Causey, Raymond Dwek, Paul Mahon, David Zaccardelli, Christopher Patusky, Richard Giltner, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, MAHON PAUL A, Judy D. Olian, DWEK RAYMOND, Tommy G. Thompson, R Paul Gray, and Louis W Sullivan

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 288 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $208,919,524.62.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Sept. 22, 2022.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Roger Jeffs with a total value of $6,551,000.00 on Sept. 23, 2014.